当前位置: 首页 > 期刊 > 《心脑血管病防治》 > 2019年第3期
编号:13373311
单纯累及肺动脉的多发性大动脉炎合并重度肺动脉高压1例(2)
http://www.100md.com 2019年6月1日 《心脑血管病防治》 2019年第3期
     [3]Alibaz-Oner F, Dede F, Ones T, et al. Patients with Takayasu's arteritis having persistent acute-phase response usually have an increased major vessel uptake by 18F-FDG-PET/CT[J]. Mod Rheumatol,2015,25(5):752-755.

    [4]Chrapko BE, Chrapko M, Nocuń A, et al. Role of 18F-FDG PET/CT in the diagnosis of inflammatory and infectious vascular disease[J]. Nucl Med Rev Cent East Eur,2016,19(1):28-36.

    [5]Qin L, Hong-Liang Z, Zhi-Hong L, et al. Percutaneous transluminal angioplasty and stenting for pulmonary stenosis due to Takayasu's arteritis: clinical outcome and four-year follow-up[J]. Clin Cardiol,2009,32(11):639-643.

    [6]Galie N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension[J]. Rev Esp Cardiol (Engl Ed),2016,69(2):177.

    [7]Ueno M. Antiplatelet therapy in the treatment of Takayasu arteritis[J]. Circ J,2010,74:1079-1080.

    [8]Szabo MZ, Kiss E. Recent advances in the treatment of large vessel vasculitides[J]. Orv Hetil,2017,158(1):5-12.

    [9]Ferrante A, Ciccia F, Guggino G, et al. Tocilizumab therapy for unresponsive pulmonary arterial hypertension in a patient with Takayasu arteritis[J]. Scand J Rheumatol,2016,45(3):251-252.

    (收稿日期:2018-11-20), 百拇医药(朱钢杰 杨建敏 徐鹏)
上一页1 2